Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cells
Schizophrenia is a mental disease that results in decreased life expectancy and wellbeing, by promoting obesity and sedentary lifestyles. Schizophrenia is treated by antipsychotic drugs. While the second generation of antipsychotics (SGA), Olanzapine and Aripiprazole are more effective in treating s...
| Autores: | , , , , , , , , , , , , |
|---|---|
| Tipo de documento: | artigo |
| Estado: | Versión aceptada para publicación |
| Data de publicação: | 2020 |
| País: | España |
| Recursos: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositório: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/222081 |
| Acesso em linha: | http://hdl.handle.net/10261/222081 |
| Access Level: | Acceso aberto |
| id |
ES_ce66b3f18cd9a67b3f8b8723bb2029e9 |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/222081 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cellsForno, FrancescaMaatuf, YossiBoukeileh, ShathaDipta, PriyaMahameed, MohamedDarawshi, OdaiFerreira, VítorRada, PatriciaGarcía Martínez, IrmaGross, EinavPriel, AviValverde, Ángela M.Tirosh, BoazSchizophrenia is a mental disease that results in decreased life expectancy and wellbeing, by promoting obesity and sedentary lifestyles. Schizophrenia is treated by antipsychotic drugs. While the second generation of antipsychotics (SGA), Olanzapine and Aripiprazole are more effective in treating schizophrenia, they display a higher risk of metabolic side effects, mostly by development of diabetes and insulin resistance, weight gain as well as dyslipidemia. Endoplasmic reticulum (ER) stress is induced when ER homeostasis of lipid biosynthesis and protein folding is impaired. This leads to the activation of the unfolded protein response (UPR), a signaling cascade that aims to restore ER homeostasis or initiate cell death. Chronic conditions of ER stress in the liver are associated with diabetes and perturbed lipid metabolism. These metabolic dysfunctions resemble the pharmacological side effects of SGAs. We, therefore, investigated whether SGAs promote the UPR in human and mouse hepatocytes. We observed full-fledged activation of ER stress by Aripiprazole, not by Olanzapine. This occurred at low micromolar concentrations and to variable intensities in different cell types, such as hepatocellular carcinoma, melanoma and glioblastoma. Mechanistically, Aripiprazole caused depletion of ER calcium, leading to activation of IRE1 and PERK, two major transducers of the UPR. Cells underwent apoptosis upon Aripiprazole treatment, which coincided with UPR induction, and this effect was reduced by adding glutathione without affecting UPR itself. Deletion of IRE1 from HepG2 cells protected cells from Aripiprazole toxicity. Our study reveals for the first time a cytotoxic effect of Aripiprazole that involves the induction of ER stress.FF, PD and VF are Marie Curie fellows [Treatment H2020-MSCA-ITN721236]. AMV, PR and IGM were supported by grants [RTI2018-094052-B-100] (MCIU/AEI/FEDER, UE)) and [S2017/BMD-3684] MOIR2-CM (Comunidad de Madrid, Spain) and CIBERdem (ISCIII, Spain).Peer reviewedAmerican Society for Pharmacology and Experimental TherapeuticsEuropean CommissionAgencia Estatal de Investigación (España)Ministerio de Ciencia, Innovación y Universidades (España)Comunidad de MadridInstituto de Salud Carlos IIIConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202020202020info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Postprintinfo:eu-repo/semantics/acceptedVersionhttp://hdl.handle.net/10261/222081reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/EC/H2020/721236info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-094052-B-100RTI2018-094052-B-100/AEI/10.13039/501100011033S2017/BMD-3684/MOIR2-CMForno, Francesca; Maatuf, Yossi; Boukeileh, Shatha; Dipta, Priya; Mahameed, Mohamed; Darawshi, Odai; Ferreira, Vítor; Rada, Patricia; García Martínez, Irma; Gross, Einav; Priel, Avi; Valverde, Ángela M.; Tirosh, Boaz. (2020): "Dataset related to article: Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cells [Dataset]", http://dx.doi.org/10.20350/digitalCSIC/13925https://doi.org/10.1124/jpet.119.264481Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/2220812026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cells |
| title |
Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cells |
| spellingShingle |
Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cells Forno, Francesca |
| title_short |
Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cells |
| title_full |
Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cells |
| title_fullStr |
Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cells |
| title_full_unstemmed |
Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cells |
| title_sort |
Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cells |
| dc.creator.none.fl_str_mv |
Forno, Francesca Maatuf, Yossi Boukeileh, Shatha Dipta, Priya Mahameed, Mohamed Darawshi, Odai Ferreira, Vítor Rada, Patricia García Martínez, Irma Gross, Einav Priel, Avi Valverde, Ángela M. Tirosh, Boaz |
| author |
Forno, Francesca |
| author_facet |
Forno, Francesca Maatuf, Yossi Boukeileh, Shatha Dipta, Priya Mahameed, Mohamed Darawshi, Odai Ferreira, Vítor Rada, Patricia García Martínez, Irma Gross, Einav Priel, Avi Valverde, Ángela M. Tirosh, Boaz |
| author_role |
author |
| author2 |
Maatuf, Yossi Boukeileh, Shatha Dipta, Priya Mahameed, Mohamed Darawshi, Odai Ferreira, Vítor Rada, Patricia García Martínez, Irma Gross, Einav Priel, Avi Valverde, Ángela M. Tirosh, Boaz |
| author2_role |
author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
European Commission Agencia Estatal de Investigación (España) Ministerio de Ciencia, Innovación y Universidades (España) Comunidad de Madrid Instituto de Salud Carlos III Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| description |
Schizophrenia is a mental disease that results in decreased life expectancy and wellbeing, by promoting obesity and sedentary lifestyles. Schizophrenia is treated by antipsychotic drugs. While the second generation of antipsychotics (SGA), Olanzapine and Aripiprazole are more effective in treating schizophrenia, they display a higher risk of metabolic side effects, mostly by development of diabetes and insulin resistance, weight gain as well as dyslipidemia. Endoplasmic reticulum (ER) stress is induced when ER homeostasis of lipid biosynthesis and protein folding is impaired. This leads to the activation of the unfolded protein response (UPR), a signaling cascade that aims to restore ER homeostasis or initiate cell death. Chronic conditions of ER stress in the liver are associated with diabetes and perturbed lipid metabolism. These metabolic dysfunctions resemble the pharmacological side effects of SGAs. We, therefore, investigated whether SGAs promote the UPR in human and mouse hepatocytes. We observed full-fledged activation of ER stress by Aripiprazole, not by Olanzapine. This occurred at low micromolar concentrations and to variable intensities in different cell types, such as hepatocellular carcinoma, melanoma and glioblastoma. Mechanistically, Aripiprazole caused depletion of ER calcium, leading to activation of IRE1 and PERK, two major transducers of the UPR. Cells underwent apoptosis upon Aripiprazole treatment, which coincided with UPR induction, and this effect was reduced by adding glutathione without affecting UPR itself. Deletion of IRE1 from HepG2 cells protected cells from Aripiprazole toxicity. Our study reveals for the first time a cytotoxic effect of Aripiprazole that involves the induction of ER stress. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020 2020 2020 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Postprint info:eu-repo/semantics/acceptedVersion |
| format |
article |
| status_str |
acceptedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/222081 |
| url |
http://hdl.handle.net/10261/222081 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
#PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/EC/H2020/721236 info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-094052-B-100 RTI2018-094052-B-100/AEI/10.13039/501100011033 S2017/BMD-3684/MOIR2-CM Forno, Francesca; Maatuf, Yossi; Boukeileh, Shatha; Dipta, Priya; Mahameed, Mohamed; Darawshi, Odai; Ferreira, Vítor; Rada, Patricia; García Martínez, Irma; Gross, Einav; Priel, Avi; Valverde, Ángela M.; Tirosh, Boaz. (2020): "Dataset related to article: Aripiprazole cytotoxicity coincides with activation of the unfolded protein response in human hepatic cells [Dataset]", http://dx.doi.org/10.20350/digitalCSIC/13925 https://doi.org/10.1124/jpet.119.264481 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
American Society for Pharmacology and Experimental Therapeutics |
| publisher.none.fl_str_mv |
American Society for Pharmacology and Experimental Therapeutics |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869419987916029952 |
| score |
15,811543 |